XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422LAA5. A total of 4 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,750 | -10.4% | 250,000 | 0.0% | 0.22% | -21.5% |
| Q2 2023 | $272,172 | +2.2% | 250,000 | 0.0% | 0.28% | +69.1% |
| Q1 2023 | $266,223 | +29.0% | 250,000 | 0.0% | 0.16% | 0.0% |
| Q4 2022 | $206,400 | -11.4% | 250,000 | 0.0% | 0.16% | +73.7% |
| Q3 2022 | $233,000 | +2.6% | 250,000 | 0.0% | 0.10% | +75.9% |
| Q2 2022 | $227,000 | -21.5% | 250,000 | 0.0% | 0.05% | -20.6% |
| Q1 2022 | $289,000 | -6.8% | 250,000 | 0.0% | 0.07% | +17.2% |
| Q4 2021 | $310,000 | +4.7% | 250,000 | 0.0% | 0.06% | -44.2% |
| Q3 2021 | $296,000 | -24.5% | 250,000 | 0.0% | 0.10% | -34.6% |
| Q2 2021 | $392,000 | -7.5% | 250,000 | 0.0% | 0.16% | +50.0% |
| Q1 2021 | $424,000 | -3.4% | 250,000 | 0.0% | 0.11% | -51.2% |
| Q4 2020 | $439,000 | – | 250,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 2,950,000 | $3,038,500 | 0.24% |
| Saltoro Capital, LP | 250,000 | $243,750 | 0.22% |
| LAZARD ASSET MANAGEMENT LLC | 11,500,000 | $11,212 | 0.02% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |